dkn-01
Showing 1 - 9 of 9
Endometrial Cancer Trial in Houston (DKN-01, Pembrolizumab)
Not yet recruiting
- Endometrial Cancer
- DKN-01
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Feb 27, 2023
Colorectal Cancer, Colorectal Adenocarcinoma, Colo-rectal Cancer Trial (DKN-01, FOLFIRI, Bevacizumab)
Not yet recruiting
- Colorectal Cancer
- +3 more
- DKN-01
- +3 more
- (no location specified)
Jul 28, 2022
Esophageal Tumor, Adenocarcinoma of the Gastroesophageal Junction, GastroEsophageal Cancer Trial in United States (DKN-01)
Available
- Esophageal Neoplasm
- +9 more
- DKN-01
-
Birmingham, Alabama
- +3 more
Aug 24, 2022
Esophageal Tumors, Adenocarcinoma of the Gastroesophageal Junction, Gastroesophageal Cancer Trial in United States (DKN-01,
Completed
- Esophageal Neoplasms
- +4 more
- DKN-01
- +2 more
-
Los Angeles, California
- +9 more
Sep 9, 2021
Esophageal Cancer, Biliary Tract Cancer, GastroEsophageal Cancer Trial (DKN-01, Atezolizumab, Paclitaxel)
Withdrawn
- Esophageal Cancer
- +3 more
- DKN-01
- +2 more
- (no location specified)
Feb 3, 2020
Carcinoma of Intrahepatic and Extra-hepatic Biliary System, Carcinoma of Gallbladder, Bile Duct Cancer Trial in United States
Completed
- Carcinoma of Intrahepatic and Extra-hepatic Biliary System
- +3 more
- DKN-01
- +2 more
-
Los Angeles, California
- +8 more
Sep 6, 2018